By Representative Fiola of Fall River, a petition (accompanied by bill, House, No. 1363) of Carole A. Fiola, Christopher Hendricks and Christopher M. Markey for legislation to extend enhanced Medicaid benefits to eligible hospitals. Health Care Financing.
This bill extends extra Medicaid payments to specific hospitals that received enhanced benefits under a 2020 law. Eligible hospitals - non-profit or municipal acute care facilities that got enhanced Medicaid payments in 2021-2022 - will receive monthly payments equal to 5% of their average monthly Medicaid payments for inpatient and outpatient services from the previous year. Payments are capped at $35 million total annually and cannot reduce existing Medicaid payments or be used to calculate future payments. The bill ensures these additional funds are provided directly to qualifying hospitals without offsetting their regular Medicaid reimbursements.
HD 2335 requires health insurers and Medicaid plans in Massachusetts to cover biomarker testing for patients when the test is supported by medical evidence, such as FDA approvals, CMS guidelines, or nationally recognized clinical practice guidelines. It directly affects patients needing personalized treatment (e.g., cancer care) and insurers, mandating coverage for diagnosis, treatment, or monitoring of diseases. Key provisions include strict timelines for prior authorization decisions (72 hours standard, 24 hours in emergencies), limits on requiring multiple biopsies, and clear processes for patients to appeal coverage denials. The bill ensures access to evidence-based testing without unnecessary delays or disruptions in care.
SD 532 requires health insurers and government health plans to cover biomarker testing for diagnosis, treatment, and monitoring of diseases when supported by specific evidence, including FDA approvals, clinical guidelines, or CMS determinations. It directly affects patients enrolled in Commonwealth group insurance (e.g., state employees) and Medicaid beneficiaries. The bill mandates coverage without unnecessary disruptions (like multiple biopsies) and sets strict timelines: insurers must approve or deny prior authorization requests within 72 hours (24 hours for urgent cases), with requests deemed approved if no response is received. Patients and providers also gain access to clear processes for appealing coverage denials.
By Mr. Cronin, a petition (accompanied by bill, Senate, No. 846) of John J. Cronin for legislation relative to the sustainability of high public payer community hospitals. Health Care Financing.
This bill requires health insurance plans covering commonwealth employees (under group insurance) and Medicaid enrollees to cover biomarker testing - tests analyzing tissue or blood to identify biological markers for guiding treatment - when supported by medical evidence like FDA approvals, clinical guidelines, or CMS determinations. Insurers must approve or deny prior authorization requests within 72 hours (24 hours in emergencies), with automatic approval if no response is given. The bill also mandates coverage without unnecessary disruptions, such as multiple biopsies, to ensure continuous patient care.
By Representative Moran of Lawrence, a petition (accompanied by bill, House, No. 1392) of Frank A. Moran relative to vaccine administration reimbursement rates for Medicaid. Health Care Financing.
